在慢性阻塞性肺病中评估新型心血管生物标志物
Kumiko Hiramatsu1,2, Takashi Motegi3, Keiko Morii3
1Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. kumiko@rcc-icr.com.
BMC pulmonary medicine
|November 29, 2024
概括
加勒-3 (Gal-3) 水平与心血管生物标志物如NT-proBNP和COPD患者的运动能力相关. 这表明Gal-3可能有助于在患有慢性阻塞性肺病 (COPD) 和COPD前患者中识别心血管并发症.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
背景情况:
- 心血管疾病经常与慢性阻塞性肺病 (COPD) 和COPD前期同时发生,显著增加了发病率和死亡率.
- 研究COPD患者心血管并发症的生物标志物对于改善患者的治疗结果至关重要.
研究的目的:
- 确定加勒-3 (Gal-3) 水平是否与COPD和COPD前患者的心血管生物标志物和心肺功能相关.
- 评估Gal-3作为该人群中心血管并发症标志物的潜力.
主要方法:
- 招募有或没有COPD的社区成年人.
- 测量生物标志物包括加勒-3 (Gal-3),高灵敏度心脏素T (hs-cTnT) 和N-终端亲脑尿素 (NT-proBNP).
- 进行肺功能测试,胸部CT,心声图和6分钟步行测试以评估心肺功能.
主要成果:
- 在6分钟的步行测试中,Gal-3水平与NT-proBNP有显著的相关性,与最大脉冲率有负相关性.
- 在Gal-3和hs-cTnT之间没有发现显著的相关性.
- hs-cTnT水平与年龄,FEV1%,E/A比率,步行距离,减速时间,右心室缩压和hs-CRP显著相关.
结论:
- 在COPD和COPD前患者中,Gal-3水平与NT-proBNP和最大脉率相关.
- 这些发现支持对Gal-3作为COPD人群中心血管并发症的潜在生物标志物的研究.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K